tiprankstipranks
Advertisement
Advertisement

CTXR Stock Latest News

Citius Oncology provides update on commercial launch of Lymphir
The FlyCitius Oncology provides update on commercial launch of Lymphir
19h ago
CTOR
CTXR
Citius Highlights LYMPHIR Combo Data in Gynecologic Cancers
PremiumCompany Announcements
Citius Highlights LYMPHIR Combo Data in Gynecologic Cancers
2M ago
8K
CTXR
Citius Oncology highlights Phase 1 data evaluating Lymphir at ASCO
PremiumThe Fly
Citius Oncology highlights Phase 1 data evaluating Lymphir at ASCO
2M ago
CTOR
CTXR
CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
PremiumWeekend Updates
CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
2M ago
AMT
CTMX
Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders
PremiumThe Fly
Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders
2M ago
CTXR
Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright
PremiumThe FlyCitius Pharmaceuticals assumed with a Buy at H.C. Wainwright
2M ago
CTXR
Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility
Premium
Company Announcements
Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility
2M ago
8K
CTXR
Citius Expands LYMPHIR Access with First European Shipment
Premium
Company Announcements
Citius Expands LYMPHIR Access with First European Shipment
3M ago
8K
CTXR
Citius Oncology announces initial shipment of LYMPHIR to Europe
PremiumThe Fly
Citius Oncology announces initial shipment of LYMPHIR to Europe
3M ago
CTOR
CTXR
Citius Pharmaceuticals Raises $5 Million in Securities Offering
PremiumCompany Announcements
Citius Pharmaceuticals Raises $5 Million in Securities Offering
3M ago
8K
CTXR
Citius Pharmaceuticals announces $5M registered direct offering priced ATM
PremiumThe Fly
Citius Pharmaceuticals announces $5M registered direct offering priced ATM
3M ago
CTXR
Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results
PremiumCompany Announcements
Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results
4M ago
8K
CTXR
Citius Oncology advances LYMPHIR launch and global expansion
PremiumCompany AnnouncementsCitius Oncology advances LYMPHIR launch and global expansion
4M ago
8K
CTXR
Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
Premium
Company Announcements
Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
4M ago
8K
CTXR
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
Premium
Company Announcements
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
5M ago
8K
CTXR
Citius Pharmaceuticals receives $3.8M through NJEDA program
PremiumThe Fly
Citius Pharmaceuticals receives $3.8M through NJEDA program
5M ago
CTXR
Citius Pharmaceuticals Posts First Revenue Amid Listing Risk
PremiumCompany Announcements
Citius Pharmaceuticals Posts First Revenue Amid Listing Risk
5M ago
8K
CTXR
Citius Oncology reports Q1 EPS (6c) vs. (9c) last year
PremiumThe Fly
Citius Oncology reports Q1 EPS (6c) vs. (9c) last year
5M ago
CTOR
CTXR
Citius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
PremiumThe Fly
Citius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
5M ago
CTOR
CTXR
Citius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
PremiumThe FlyCitius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
5M ago
CTOR
CTXR
Is CTXR a Buy, Before Earnings?
Premium
Pre-Earnings
Is CTXR a Buy, Before Earnings?
6M ago
CTXR
Citius Oncology to sell 1.28M shares at $1.09 in registered direct offering
Premium
The Fly
Citius Oncology to sell 1.28M shares at $1.09 in registered direct offering
7M ago
CTOR
CTXR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >